Bel Fuse-B
BELFB
246.72
-13.54
-5.20%
Bel Fuse-B
US · BELFB
#2335 by market cap
Listed 1970
246.72
-13.54
-5.20%
Live - 5344 symbols - heartbeat 32s ago
· 2026-10-08 08:24
Pre-market
242.31
-1.79%
After-hours
246.72
0.00%
- Market cap
- 3.56B
- P/E (TTM)i
- 59.45
- P/Bi
- 3.92
- EPSi
- 4.90
- Div yieldi
- 0.11%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on BELFB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.17, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +26.30% YoY
Margins
- Gross margin
- 39.15%
- Operating margin
- 15.95%
- Net margin
- 9.11%
Key ratios & quality
- Enterprise valuei
- 3.71B
- PEG ratioi
- 11.20
- Altman Z-Scorei
- 7.17
PEG uses trailing P/E against the 3-year net income growth rate (5.31%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 548.18M | 492.41M | 465.77M | 543.49M | 654.23M | 639.81M | 534.79M | 675.46M |
| Gross profit | 139.26M | 109.97M | 119.73M | 134.38M | 183.45M | 215.85M | 202.36M | 264.42M |
| Selling & admin expenses | 82.60M | 77.42M | 78.70M | 86.61M | 92.34M | 99.09M | 110.62M | 125.83M |
| Research & development | 29.49M | 26.93M | 23.61M | 21.89M | 20.24M | 22.49M | 23.59M | 30.87M |
| Operating profit | 27.17M | 5.63M | 17.42M | 25.88M | 70.87M | 94.27M | 68.16M | 107.72M |
| Pretax profit | 23.62M | -7.30M | 12.14M | 27.33M | 59.06M | 83.30M | 61.81M | 95.05M |
| Tax | 2.91M | 1.44M | -659.00K | 2.51M | 6.37M | 9.47M | 12.62M | 20.94M |
| Net profit | 20.71M | -8.74M | 12.80M | 24.82M | 52.69M | 73.83M | 49.19M | 74.11M |
| Basic EPS | 2 | -1 | 1 | 2 | 4 | 6 | 3 | 5 |
| Diluted EPS | 1.73 | -0.71 | 1.05 | 2.02 | 4.01 | 5.52 | 3.10 | 4.65 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 152.24M | 168.30M | 178.98M | 175.94M | 178.49M | 210.69M |
| Gross profit | 58.82M | 65.08M | 71.14M | 69.38M | 69.60M | 83.97M |
| Selling & admin expenses | 29.51M | 30.91M | 32.80M | 32.60M | 36.73M | 36.29M |
| Research & development | 7.22M | 8.10M | 7.55M | 7.99M | 8.51M | 9.01M |
| Operating profit | 22.09M | 26.07M | 30.79M | 28.78M | 24.36M | 38.68M |
| Pretax profit | 23.79M | 33.70M | 28.00M | 9.56M | 17.79M | 37.76M |
| Tax | 5.46M | 6.91M | 5.45M | 3.12M | 2.81M | 3.79M |
| Net profit | 18.32M | 26.79M | 22.56M | 6.44M | 14.98M | 33.98M |
| Basic EPS | 1 | 2 | 2 | 0 | 1 | 2 |
| Diluted EPS | 1.36 | 2.14 | 1.68 | -0.42 | 0.86 | 1.89 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 290.51M | 283.18M | 280.22M | 329.02M | 381.41M | 381.48M | 373.53M | 384.76M |
| Cash & ST investments | 53.91M | 72.29M | 84.94M | 61.76M | 70.27M | 126.92M | 69.20M | 57.80M |
| Inventory | 120.07M | 107.28M | 100.13M | 139.38M | 172.47M | 136.54M | 161.37M | 167.27M |
| Total assets | 443.52M | 468.92M | 453.87M | 511.85M | 560.47M | 571.63M | 949.79M | 935.20M |
| Total current liabilities | 106.03M | 90.22M | 87.54M | 112.01M | 136.30M | 110.61M | 128.07M | 127.45M |
| Short-term debt | 2.51M | 12.87M | 11.88M | 6.88M | 5.87M | 6.35M | 7.95M | 8.03M |
| Long-term debt | 111.71M | 138.22M | 110.29M | 112.50M | 95.00M | 60.00M | 292.50M | 197.50M |
| Total liabilities | 267,054,000.00 | 300,866,000.00 | 268,067,000.00 | 303,103,000.00 | 298,120,000.00 | 231,073,000.00 | 508,627,000.00 | 416,526,000.00 |
| Total equity | 176.47M | 168.05M | 185.80M | 208.74M | 262.35M | 340.56M | 441.16M | 518.67M |
| Retained earnings | 168.70M | 157.06M | 166.49M | 187.94M | 237.19M | 307.51M | 345.03M | 403.10M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 368.43M | 378.62M | 387.69M | 384.76M | 397.15M | 698.73M |
| Cash & ST investments | 66.88M | 59.28M | 57.74M | 57.80M | 59.45M | 306.11M |
| Inventory | 164.82M | 164.65M | 166.11M | 167.27M | 181.23M | 200.23M |
| Total assets | 940.46M | 950.58M | 952.80M | 935.20M | 951.92M | 1.26B |
| Total current liabilities | 111.24M | 124.08M | 126.76M | 127.45M | 124.75M | 155.92M |
| Short-term debt | 8.54M | 8.69M | 8.22M | 8.03M | 7.23M | 8.75M |
| Long-term debt | 285.00M | 253.27M | 226.36M | 197.50M | 204.50M | -- |
| Total liabilities | 482,521,000.00 | 464,871,000.00 | 443,773,000.00 | 416,526,000.00 | 416,212,000.00 | 252,210,000.00 |
| Total equity | 457.94M | 485.71M | 509.03M | 518.67M | 535.71M | 1.01B |
| Retained earnings | 362.04M | 388.04M | 409.42M | 403.10M | 413.62M | 438.23M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10.10M | 24.45M | 46.11M | 4.63M | 40.26M | 108.35M | 74.06M | 80.61M |
| Depreciation & amortization | 18.21M | 16.47M | 16.42M | 16.86M | 14.86M | 13.31M | 16.46M | 26.59M |
| Free cash flow | -1.50M | 14.56M | 40.63M | -4.77M | 31.43M | 96.22M | 59.96M | 68.61M |
| Dividends paid | -3.30M | -3.35M | -3.36M | -3.38M | -3.41M | -3.49M | -3.45M | -3.47M |
| Stock buybacks / issuance | 0 | -448.00K | -- | 0 | -349.00K | -105.00K | -16.05M | 0 |
| Ending cash balance | 53.91M | 72.29M | 84.94M | 61.76M | 70.27M | 89.37M | 68.25M | 57.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 8.15M | 20.72M | 22.18M | 29.57M | 13.83M | 17.93M |
| Depreciation & amortization | 6.68M | 6.60M | 6.65M | 6.66M | 6.62M | 6.91M |
| Free cash flow | 5.36M | 16.79M | 20.32M | 26.14M | 11.19M | 15.69M |
| Dividends paid | -829.00K | -831.00K | -834.00K | -971.00K | -840.00K | -844.00K |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 65.93M | 59.28M | 57.74M | 57.80M | 59.45M | 306.11M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.38 | -5.08 | 7.23 | 12.58 | 22.37 | 24.49 | 11.68 | 15.66 |
| ROA %i | 4.73 | -1.92 | 2.77 | 5.14 | 9.83 | 13.04 | 5.38 | 6.53 |
| ROIC %i | 8.88 | -1.53 | 5.03 | 8.51 | 15.44 | 19.09 | 7.35 | 10.90 |
| 5-year avg ROE %i | -3.21 | -4.99 | -5.22 | 3.92 | 9.90 | 12.32 | 15.67 | 17.36 |
| EBIT margin %i | 5.28 | -0.38 | 3.62 | 5.68 | 9.54 | 13.46 | 12.32 | 16.26 |
| FCF / sales %i | -- | 2.96 | 8.72 | -- | 4.80 | 15.04 | 11.21 | 10.16 |
| Current ratioi | 2.74 | 3.14 | 3.20 | 2.94 | 2.80 | 3.45 | 2.92 | 3.02 |
| Quick ratioi | 1.52 | 1.83 | 1.95 | 1.58 | 1.44 | 2.02 | 1.45 | 1.48 |
| Debt / assetsi | 25.75 | 34.73 | 28.69 | 26.19 | 20.81 | 14.09 | 33.50 | 23.67 |
| LT debt / equityi | 63.30 | 89.24 | 63.70 | 60.92 | 42.21 | 21.79 | 86.05 | 50.14 |
| Interest coveragei | 5.44 | -0.34 | 3.56 | 8.72 | 18.48 | 30.23 | 16.16 | 7.44 |
| Revenue CAGR (3Y) %i | -1.12 | -0.52 | -1.78 | -0.29 | 9.93 | 11.16 | -0.54 | 1.07 |
| Net income CAGR (3Y) %i | 2.56 | -- | -- | 6.22 | -- | 79.36 | 18.17 | 5.31 |
| FCF CAGR (3Y) %i | -- | -21.74 | 31.93 | -- | 29.24 | 33.29 | -- | 29.73 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.87 | 13.40 | 16.40 | 15.66 | 13.49 | 8.17 |
| ROA %i | 5.74 | 6.72 | 8.48 | 6.53 | 5.82 | 4.85 |
| ROIC %i | 8.25 | 10.26 | 13.37 | 10.90 | 9.57 | 7.52 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.07 | 14.72 | 16.55 | 16.26 | 14.56 | 13.98 |
| FCF / sales %i | 11.11 | 8.09 | 6.87 | 10.16 | 10.61 | 9.86 |
| Current ratioi | 3.31 | 3.05 | 3.06 | 3.02 | 3.18 | 4.48 |
| Quick ratioi | 1.58 | 1.51 | 1.52 | 1.48 | 1.51 | 3.03 |
| Debt / assetsi | 33.06 | 29.28 | 26.18 | 23.67 | 23.76 | 2.71 |
| LT debt / equityi | 80.22 | 66.62 | 56.40 | 50.14 | 49.87 | 2.81 |
| Interest coveragei | 9.37 | 7.69 | 7.37 | 7.44 | 7.78 | 9.51 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Aerospace, Defense & Rugged Solutions is the largest reported line at 52.43% of revenue, across 2 reported segments.
- Industrial Technology & Data Solutions follows at 47.57%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Aerospace, Defense & Rugged Solutions52.43%
Industrial Technology & Data Solutions47.57%
Quote time 2026-10-08 08:24:00 · For reference only, not investment advice and not tailored to your situation.